EC Number |
Inhibitors |
Structure |
---|
3.5.4.12 | (4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid |
decreases the enzyme activity in vivo in transformed NM-16 fibroblasts, but increases it in normal Rat-2 fibroblasts |
|
3.5.4.12 | 2',2'-difluoro-dCTP |
dual mechanism of inhibition; partial purified enzyme |
|
3.5.4.12 | 2',2'-difluorodeoxycytidine |
high cellular nucleotide levels: inhibition: Concentration-dependent inhibition; inhibition by nucleotides of 2',2'-difluorodeoxycytidine, dual mechanism of inhibition |
|
3.5.4.12 | 2',3'-di-dTTP |
7% inhibition |
|
3.5.4.12 | 2',3'-dihydro-2',3'-dideoxy-thymidine monophosphate |
- |
|
3.5.4.12 | 2'-beta-D-deoxyribose-pyrimidin-2-one 5'-phosphate |
competitive inhibition, Ki: 0.000012 mM |
|
3.5.4.12 | 2'-deoxythymidine |
0.05 mM: 60% inhibition, 0.01 mM: 5% inhibition; dThd |
|
3.5.4.12 | 3'-azido-2',3'-dideoxy-thymidine monophosphate |
- |
|
3.5.4.12 | 3,4,5,6-tetrahydro-2'-deoxyuridine |
- |
|
3.5.4.12 | 3,4,5,6-tetrahydro-2'-deoxyuridine |
specifc inhibition |
|